Skip to content

The effect of desmopressin in reducing the incidence of heart transplant surgery complication

Comparison of desmopressin with placebo, in Hemostasis after heart transplant surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015010512642N8
Enrollment
40
Registered
2015-01-25
Start date
2015-02-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transplant cardiac surjery. Surgical operation with transplant of whole organ

Interventions

Intervention 1: Prescribed 0.3ug / kg desmopressin with 2 ml volume before transplant surgery. Intervention 2: 2 mL of saline administered before transplantation.
Prevention
Prescribed 0.3ug / kg desmopressin with 2 ml volume before transplant surgery
2 mL of saline administered before transplantation

Sponsors

Vice Chancellor for Research and Technological Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age between 20-70 years old; Heart transplant surgery exclusion criteria: History of previous surgery on chest; Bleeding disorders and hemophilia; Patients with preoperative coagulation tests and platelet be disrupted; Contraindications for use of DDAVP; History of deep vein thrombosis-hematologic disease- carotid plaque due to sever narrowing; Chronic obstructive pulmonary disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chest tube blood volume. Timepoint: During the first 24 hours after surgery. Method of measurement: cc with a calibrated container.;Blood volume required for transfusion. Timepoint: During the first 24 hours after surgery. Method of measurement: Based on the number of units transfused.;FFP volume required for transfusion. Timepoint: During the first 24 hours after surgery. Method of measurement: Based on the number of units injected.

Secondary

MeasureTime frame
Thrombin time. Timepoint: before and after transplant surjery. Method of measurement: According to the second with lab kit.;Platelet count. Timepoint: Before and after transplantat surjery. Method of measurement: Based on the number of platelets per ml of blood.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026